홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ENGN
#2490
enGene Holdings Inc. Common Stock
10.110
0
+0.20%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+0.20%
월간 변동
-9.25%
6달 변화
+20.36%
년간 변동율
+20.36%
이전 종가
10.090
0
Open
10.110
0
Bid
Ask
Low
10.110
0
High
10.110
0
양
9
마켓
주식
헬스케어
ENGN
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2023
2024
2025
TTM
Key stats
Total common shares outstanding
23.2 M
50.98 M
66.98 M
—
Valuation ratios
Enterprise value
382.44 M
278.14 M
432.76 M
1.03 B
Price to earnings ratio
0.13
6.06
3.15
12.28
Price to sales ratio
3.87
848.66
122.86 K
146.96 K
Price to cash flow ratio
0.56
6.92
3.72
12.51
Price to book ratio
0.19
1.23
2.2
2.86
Enterprise value to EBITDA ratio
—
—
—
—
Profitability ratios
Return on assets %
1.15
0.18
0.53
0.47
Return on equity %
1.38
0.2
0.7
0.58
Return on invested capital %
3 669.8
660.95
879.54
892.76
Gross margin %
100
100
100
400
Operating margin %
727.93
15.81 K
4.11 M
265.26 K
EBITDA margin %
—
—
—
—
Net margin %
2 790.98
14 K
3.91 M
257.65 K
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
16.25
16.87
6.3
46.46
Inventory turnover
—
—
—
—
Asset turnover
0.04
0
0
-0
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
0.11
0.07
0.07
0.29
Long term debt to total equity ratio
0.13
0.08
0.09
0.35
Per share metrics
Operating cash flow per share
35.66
1.28
1.94
1.94
EBIT per share
—
—
—
—
EBITDA per share
—
—
—
—
Total debt per share
—
—
—
—
Cash per share
117.7
6.31
3.79
16.2
Net current asset value per share
123.36
6.55
3.94
16.91
Tangible book value per share
104.66
7.22
3.28
16.57
Working capital per share
115.77
6.16
3.31
15.28
Book value per share
104.66
7.22
3.28
16.57
뉴스
톱 SMID 캡 바이오, 모건 스탠리 주목
Top SMID Cap Biotech Stocks to Watch According to Morgan Stanley
3 Best Stocks to Buy Today, 1/30/2026, According to Top Analysts - TipRanks.com
제퍼리스, 에네진 홀딩스에 대해 ’매수’ 등급으로 커버리지 개시
Jefferies initiates coverage on Engene stock with Buy rating
enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 (NASDAQ:ENGN)
Citizens, 유진 주식 ’시장 수익률 상회’ 등급 재확인, 목표가 21달러
Citizens reiterates Market Outperform rating on Engene stock with $21 target
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
엔젠 주식, H.C. 웨인라이트, NMIBC 치료 이점으로 매수 유지
Engene stock remains a Buy at H.C. Wainwright on NMIBC treatment advantages
CG Oncology Undervalued Going Into A Busy 2026 (NASDAQ:CGON)